Combination Drug for HCV Infection.

@article{Voelker2017CombinationDF,
  title={Combination Drug for HCV Infection.},
  author={Rebecca Voelker},
  journal={JAMA},
  year={2017},
  volume={318 9},
  pages={
          790
        }
}
A new 3-drug combination medication for adults with chronic hepatitis C virus (HCV) infection has received FDA approval. The drug is indicated for patients with any of 6 viral genotypes who have either no cirrhosis or only a mild case of the liver disease. Marketed as Vosevi, the drug is a fixeddose tablet containing 2 previously approved medications—sofosbuvir and velpatasvir—and a new drug, voxilaprevir. It is the first treatment approved for patients who do not respond to the directacting… CONTINUE READING
BETA
57
Twitter Mentions